Amedeo Smart

Free Medical Literature Service

 

Amedeo

Thoracic Surgery
  Free Subscription

Articles published in
Lancet
    April 2024
  1. PRAZ F, Beyersdorf F, Haugaa K, Prendergast B, et al
    Valvular heart disease: from mechanisms to management.
    Lancet. 2024;403:1576-1589.
    >> Share

  2. HAHN RT, Muraru D, Lindman BR, Delgado V, et al
    Heart valve disease: at the threshold of a new era in patient management.
    Lancet. 2024;403:1519-1522.
    >> Share

  3. LI X, Ge Z, Kan J, Anjum M, et al
    Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial.
    Lancet. 2024 Apr 5:S0140-6736(24)00282-4. doi: 10.1016/S0140-6736(24)00282.
    >> Share

  4. DEN DEKKER WK
    Is intravascular imaging the future of percutaneous coronary intervention?
    Lancet. 2024 Apr 5:S0140-6736(24)00430-6. doi: 10.1016/S0140-6736(24)00430.
    >> Share

  5. GE Z, Kan J, Gao X, Raza A, et al
    Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.
    Lancet. 2024 Apr 5:S0140-6736(24)00473-2. doi: 10.1016/S0140-6736(24)00473.
    >> Share

  6. PARK SJ, Ahn JM, Kang DY, Yun SC, et al
    Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial.
    Lancet. 2024 Apr 4:S0140-6736(24)00413-6. doi: 10.1016/S0140-6736(24)00413.
    >> Share

  7. BOROVAC JA
    Percutaneous coronary intervention for non-obstructive vulnerable plaques.
    Lancet. 2024 Apr 4:S0140-6736(24)00488-4. doi: 10.1016/S0140-6736(24)00488.
    >> Share

    March 2024
  8. WERNLY B, Jung C
    Transfemoral transcatheter aortic valve replacement for pure aortic regurgitation.
    Lancet. 2024 Mar 26:S0140-6736(24)00062-X. doi: 10.1016/S0140-6736(24)00062.
    >> Share

  9. VAHL TP, Thourani VH, Makkar RR, Hamid N, et al
    Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study.
    Lancet. 2024 Mar 26:S0140-6736(23)02806-4. doi: 10.1016/S0140-6736(23)02806.
    >> Share

  10. LEBRETON G, Leprince P
    Successful heart transplant after 12 h preservation aboard a commercial flight.
    Lancet. 2024;403:1019.
    >> Share

    February 2024
  11. LEE ZS, Ryan N
    Intravascular imaging in percutaneous coronary intervention.
    Lancet. 2024 Feb 21:S0140-6736(23)02686-7. doi: 10.1016/S0140-6736(23)02686.
    >> Share

    January 2024
  12. LANDI A, Pedrazzini G, Wild L, Beele A, et al
    Coronary embolisation of native aortic valve debris during transcatheter aortic valve replacement: mechanical embolectomy and histopathological analysis.
    Lancet. 2024;403:e5-e6.
    >> Share

    December 2023
  13. JIMENEZ DIAZ VA, Iniguez Romo A
    Intracoronary artery visualisation of crystalline sirolimus deposits after drug-coated balloon angioplasty for acute coronary syndrome.
    Lancet. 2023;402:2111-2112.
    >> Share

    November 2023
  14. MESSAS E, Ijsselmuiden A, Trifunovic-Zamaklar D, Cholley B, et al
    Treatment of severe symptomatic aortic valve stenosis using non-invasive ultrasound therapy: a cohort study.
    Lancet. 2023 Nov 13:S0140-6736(23)01518-0. doi: 10.1016/S0140-6736(23)01518.
    >> Share

  15. DI MARIO C, Mattesini A
    Non-invasive high-energy ultrasound: alternative treatment before transcatheter aortic valve implantation?
    Lancet. 2023 Nov 13:S0140-6736(23)02186-4. doi: 10.1016/S0140-6736(23)02186.
    >> Share

    October 2023
  16. VERHEMEL S, Van Mieghem NM
    Revalving to treat transcatheter valve failure.
    Lancet. 2023;402:1500-1501.
    >> Share

  17. KHO SS, Chai CS, Ho RL, Ismail AM, et al
    Pulmonary alveolar microlithiasis-a rare lung disease-diagnosed by transbronchial cryobiopsy.
    Lancet. 2023;402:1356.
    >> Share

    August 2023
  18. MAKKAR RR, Kapadia S, Chakravarty T, Cubeddu RJ, et al
    Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a registry study.
    Lancet. 2023 Aug 31:S0140-6736(23)01636-7. doi: 10.1016/S0140-6736(23)01636.
    >> Share

  19. CONEN D, Ke Wang M, Popova E, Chan MTV, et al
    Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial.
    Lancet. 2023 Aug 25:S0140-6736(23)01689-6. doi: 10.1016/S0140-6736(23)01689.
    >> Share

    May 2023
  20. BRADBURY AW, Moakes CA, Popplewell M, Meecham L, et al
    A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisatio
    Lancet. 2023;401:1798-1809.
    >> Share

    April 2023
  21. GAUDINO M, Andreotti F, Kimura T
    Current concepts in coronary artery revascularisation.
    Lancet. 2023 Apr 27:S0140-6736(23)00459-2. doi: 10.1016/S0140-6736(23)00459.
    >> Share

    March 2023
  22. PUSTJENS TFS, Vriesendorp PA, Van't Hof AWJ
    Revascularisation in acute coronary syndromes: change in practice?
    Lancet. 2023 Mar 3:S0140-6736(23)00403-8. doi: 10.1016/S0140-6736(23)00403.
    >> Share

    November 2022
  23. LI Y, Liang Z, Qin L, Wang M, et al
    Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)01999.
    >> Share

    July 2022
  24. MAHMOOD F, Topol EJ
    Digitising heart transplant rejection.
    Lancet. 2022;400:17.
    >> Share

    April 2022
  25. SAJI H, Okada M, Tsuboi M, Nakajima R, et al
    Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
    Lancet. 2022;399:1607-1617.
    >> Share

  26. LICHT PB
    When less is more in thoracic surgery.
    Lancet. 2022;399:1574-1575.
    >> Share

  27. SEKULIC SP, Sekulic M
    Atypical arrhythmogenic presentation of giant cell myocarditis diagnosed after heart transplant.
    Lancet. 2022;399:1411.
    >> Share

  28. BORGES FK, Spence J
    Challenging dogma about perioperative warming during non-cardiac surgery.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00607.
    >> Share

  29. SESSLER DI, Pei L, Li K, Cui S, et al
    Aggressive intraoperative warming versus routine thermal management during non-cardiac surgery (PROTECT): a multicentre, parallel group, superiority trial.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00560.
    >> Share

    February 2022
  30. THEODOROPOULOS KC, Liakopoulou A, Tsagkaropoulos S, Kassimis G, et al
    Under-sensing by a temporary pacemaker after cardiac surgery and ventricular fibrillation.
    Lancet. 2022;399:677.
    >> Share

  31. BODEN WE, Kaski JC, Al-Lamee R, Weintraub WS, et al
    What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?
    Lancet. 2022;399:691-694.
    >> Share

    January 2022
  32. BURKI T
    Pig-heart transplantation surgeons look to the next steps.
    Lancet. 2022;399:347.
    >> Share

    November 2021
  33. SABATINE MS, Bergmark BA, Murphy SA, O'Gara PT, et al
    Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02334.
    >> Share

  34. MEHRAN R, Owen R, Chiarito M, Baber U, et al
    A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02326.
    >> Share

  35. GAUDINO M, Sanna T, Ballman KV, Robinson NB, et al
    Posterior left pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: an adaptive, single-centre, single-blind, randomised, controlled trial.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02490.
    >> Share

  36. BELLEY-COTE EP, Devereaux PJ
    PCI versus CABG for left main coronary artery disease: is the jury still out?
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02491.
    >> Share

  37. VAN BOVEN WJ, de Groot JR, Kluin J
    A short cut to prevent postoperative atrial fibrillation.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02435.
    >> Share

  38. KANG J, Koo BK, Park KW, Shin ES, et al
    Aspirin versus clopidogrel after percutaneous coronary intervention - Authors' reply.
    Lancet. 2021;398:1685-1686.
    >> Share

  39. PAREEK M, Byrne C
    Aspirin versus clopidogrel after percutaneous coronary intervention.
    Lancet. 2021;398:1685.
    >> Share

  40. BYRNE RA, McGovern L
    Angiography-derived quantitative flow ratio guidance of coronary intervention: measure twice, cut once.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02397.
    >> Share

  41. XU B, Tu S, Song L, Jin Z, et al
    Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02248.
    >> Share

    October 2021
  42. KIM CJ, Park MW, Kim MC, Choo EH, et al
    Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised tr
    Lancet. 2021;398:1305-1316.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016